Post-Hoc Analysis Indicates Patients Treated With Isavuconazole Had OS Of 82% At 42 Days and 70% At 84 Days, Study Suggests

Healio (6/4, Stulpin) reported, “Patients treated with isavuconazole as primary or salvage therapy for invasive fungal sinusitis experienced overall survival rates of 82% at 42 days and 70% at 84 days.” The data came “from a post-hoc analysis of two phase...